Neil H. White, M.D.

Profile picture
Professor of Medicine
Endocrinology and Diabetes

phone: (314) 454-6051

Clinical Interests

Over the last 40 years, Dr. White's clinical and research interests have focused on diabetes mellitus. This includes clinical and translational research related to diabetes mellitus, both type 1 and type 2, in children and adolescents. Much of his research has been through active participation in multicenter NIH-supported clinical trials including DCCT/EDIC, DPP/DPPOS, TODAY, DirecNet, TRIGR and TrialNet. In addition to serving as local PI for these trials, he has national leadership roles in DirecNet and TODAY. Throughout his career, he has had an ongoing interest in: 1) methods of intensive therapy in type 1 diabetes; 2) the risks associated with hypoglycemia in diabetic subjects, including effects on brain structure and function; 3) studies of diabetes prevention; and 4) psychosocial interventions in teenagers with diabetes. Dr. White has also had a longstanding interest in the diagnosis and management of hypoglycemia in infants and children, including hyperinsulinism and glycogen storage disease.


  • BS, State University of New York at Albany1971
  • MD, Albert Einstein College of Medicine1975


  • Internship and Residency in Pediatrics, Washington University1975 - 1977
  • Fellowship in Pediatric Endocrinology and Metabolism, Washington Univeristy1977 - 1979

Licensure and Board Certification

  • 1976 - PresNational Board of Medical Examiners
  • 1979 - 2020MO
  • 1981 - PresAmerican Board of Pediatrics
  • 1983 - PresPediatric Endocrinology
  • 1992 - 2012Certified Diabetes Educator
  • 1992 - 2012Certified Diabetes Educator

Honors and Awards

  • Signum Laudis, Honorary Scholastic Society, SUNY at Albany1971
  • Award for Meritorious Service, American Diabetes Association, Michigan1991
  • Listed in "Best Doctors in America"1994
  • Award for Outstanding Service, American Diabetes Association1997
  • Award for Outstanding Service, American Diabetes Association1998
  • Outstanding Contribution to Camping and Diabetes, American Diabetes Association1998
  • Award for Outstanding Service, American Diabetes Association1999
  • Life Member, National Registry of Who's Who1999
  • Best Doctors in St. Louis, Pediatric Endocrinology, St. Louis Magazine2000 - Pres
  • Listed America's Top Doctors, 3rd Edition2003
  • Listed in Who's Who in America, 57th Edition2003
  • Listed America's Top Doctors, 4th edition2004
  • Listed in Castle Connolly Top Doctor Guides2004
  • Best Doctors in St. Louis, Pediatric Endocrinology, St. Louis Magazine2005 - Pres
  • Listed America's Top Doctors, 5th Edition2005
  • Who's Who in Medicine and Healthcare, 6th edition2006
  • America’s Top Doctors, Castle Connolly Medical, LTD2010 - Pres
  • Global Directory of Who’s Who (Top Doctors)2010 - Pres

Recent Publications view all (191)

Publication Co-Authors

  1. A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes. Nat Commun. 2022;13(1):4940. PMCID:PMC9427757  PMID:36042217 
  2. Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience. Diabetes Care. 2022. PMID:36098658 
  3. Deterioration of Glycemic Control in Youth-Onset Type 2 Diabetes: What Are the Early and Late Predictors? J Clin Endocrinol Metab. 2022;107(8):e3384-e3394. PMID:35486388 
  4. Longitudinal progression of diabetes mellitus in Wolfram syndrome: The Washington University Wolfram Research Clinic experience. Pediatr Diabetes. 2022;23(2):212-218. PMCID:PMC8844189  PMID:34792267 
  5. Comparison of ETDRS 7-Field to 4-Widefield Digital Imaging in the Evaluation of Diabetic Retinopathy Severity. Transl Vis Sci Technol. 2022;11(1):13. PMCID:PMC8762689  PMID:35015059 
  6. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2021;44(12):2775-2782. PMCID:PMC8669534  PMID:34697033 
  7. Risk Factors for Diabetic Peripheral Neuropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 2021. PMCID:PMC9174958  PMID:34716210 
  8. Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 2021. PMCID:PMC9174974  PMID:34531310 
  9. A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome. JCI Insight. 2021;6(15). PMID:34185708 
  10. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021;385(5):416-426. PMID:34320286 
  11. Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients. J Diabetes Investig. 2021. PMID:34309223 
  12. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep. 2021;11(1):14182. PMCID:PMC8271014  PMID:34244538 
  13. Implementation of School Diabetes Care in the United States: A Scoping Review. J Sch Nurs. 2021;10598405211026328. PMID:34184953 
  14. Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study. Diabetes Care. 2021. doi:10.2337/dc20-2125  PMID:33568403 
  15. Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010-1016. Diabetes Care. 2021;44(1):298. PMCID:PMC7783934  PMID:33158952 
  16. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial. Diabetes Care. 2021;44(1):75-80. PMCID:PMC7783942  PMID:33290248 
  17. Efficacy and Safety of Inhaled Human Insulin (Exu hera®) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial. J Pediatr Endocrinol Metab. 2020;21(6):555-568. PMID:33600687 
  18. Brain Function Differences in Children With Type 1 Diabetes: An fMRI Study of Working Memory. Diabetes. 2020. PMID:32471809 
  19. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 2020;69(5):1000-1010. PMCID:PMC7171957  PMID:32051148 
  20. DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes. Clin Epigenetics. 2020;12(1):52. PMCID:PMC7132894  PMID:32248841 
  21. Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors. Diabetes. 2020;69(1):112-120. PMCID:PMC6925585  PMID:31636172 
  22. Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program. Diabetes. 2019;68(12):2337-2349. PMCID:PMC6868469  PMID:31582408 
  23. Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019. PMID:31501226 
  24. Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study. Diabetes Care. 2019;42(8):1549-1559. PMID:31167889 
  25. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia. 2019;62(8):1319-1328. PMID:31270584 
  26. Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes Care. 2019. PMID:31320445 
  27. Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough? Pediatr Diabetes. 2019. PMID:31206973 
  28. Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2019;42(4):601-608. PMCID:PMC6429636  PMID:30877090 
  29. Risk Factors for Kidney Disease in Type 1 Diabetes. Diabetes Care. 2019. PMID:30833370 
  30. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2019. PMID:30833368 
  31. Impact of Early Diabetic Ketoacidosis on the Developing Brain. Diabetes Care. 2019;42(3):443-449. PMCID:PMC6385695  PMID:30573652 
  32. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in β-Cell Function in TODAY. Diabetes Care. 2019;42(1):164-172. PMCID:PMC6300703  PMID:30455329 
  33. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. Diabetes Care. 2018;41(12):2648-2668. PMID:30425094 
  34. Posaconazole-induced hypertension and hypokalemia due to inhibition of the 11β-hydroxylase enzyme. Clin Kidney J. 2018;11(5):691-693. PMCID:PMC6165748  PMID:30289132 
  35. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018;41(9):1887-1894. PMCID:PMC6105323  PMID:30002199 
  36. Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial Genet Med. 2018;(6):583-5990. doi:10.1038/gim.2017.150.  PMCID:5955780  PMID:29758564 
  37. Longitudinal assessment of hippocampus structure in children with type 1 diabetes. Pediatr Diabetes. 2018. PMID:29675980 
  38. Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. JAMA. 2018;319(1):38-48. PMID:29297078 
  39. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(12):1756-1762. PMCID:PMC5711332  PMID:29138273 
  40. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care. 2017;40(8):1010-1016. PMID:28550194 
  41. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. N Engl J Med. 2017;376(16):1507-1516. PMCID:PMC5557280  PMID:28423305 
  42. Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes. Diabetes. 2017;66(3):754-762. PMCID:PMC5319714  PMID:27702833 
  43. Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017;40(1):85-93. PMCID:PMC5180463  PMID:27803118 
  44. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(1):94-100. PMCID:PMC5180458  PMID:27803120 
  45. Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC. J Urol. 2016;196(4):1129-35. PMCID:PMC5025347  PMID:27131462 
  46. Severity of clinical presentation in youth with type 1 diabetes is associated with differences in brain structure. Pediatr Diabetes. 2016. PMID:27488913 
  47. Altered Integration of Structural Covariance Networks in Young Children With Type 1 Diabetes. Hum Brain Mapp. 2016. PMID:27339089 
  48. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort. Proc Natl Acad Sci U S A. 2016;113(21):E3002-11. PMCID:PMC4890596  PMID:27162351 
  49. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-61. PMCID:PMC4880159  PMID:26900641 
  50. Longitudinal Evaluation of Cognitive Functioning in Young Children with Type 1 Diabetes over 18 Months. J Int Neuropsychol Soc. 2016;22(3):293-302. PMCID:PMC4856439  PMID:26786245 
  51. Neuroimaging evidence of deficient axon myelination in Wolfram syndrome. Sci Rep. 2016;6:21167. PMCID:PMC4758056  PMID:26888576 
  52. Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes. 2016;65(2):476-85. PMCID:PMC4747456  PMID:26512024 
  53. Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience. Diabetes Care. 2016;39(1):122-9. PMCID:PMC4686849  PMID:26628417 
  54. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015;38(12):2285-92. PMCID:PMC4657618  PMID:26537182 
  55. Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. Diabetes Technol Ther. 2015;17(10):726-34. PMCID:PMC4575521  PMID:26192006 
  56. Long-term Outcomes in Youths with Diabetes Mellitus. Pediatr Clin North Am. 2015;62(4):889-909. PMCID:PMC4662600  PMID:26210623 
  57. Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management. J Pediatr. 2015;166(6):1520-1525.e1. doi:10.1016/j.jpeds.2015.02.045  PMID:25819173 
  58. Relationship between abuse and neglect in childhood and diabetes in adulthood: differential effects by sex, national longitudinal study of adolescent health. Prev Chronic Dis. 2015;12:E70. doi:10.5888/pcd12.140434  PMCID:PMC4436043  PMID:25950577 
  59. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015. doi:10.1016/j.jpeds.2015.03.057  PMID:25957977 
  60. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015;64(5):1770-9. doi:10.2337/db14-1445  PMCID:PMC4407847  PMID:25488901 
  61. Intensive diabetes therapy and ocular surgery in type 1 diabetes. N Engl J Med. 2015;372(18):1722-33. doi:10.1056/NEJMoa1409463  PMCID:PMC4465212  PMID:25923552 
  62. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study. Psychosom Med. 2015;77(3):303-10. doi:10.1097/PSY.0000000000000156  PMCID:PMC4397126  PMID:25775165 
  63. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646-53. doi:10.1210/jc.2014-3761  PMCID:PMC4399293  PMID:25706240 
  64. Remission of severe neonatal diabetes with very early sulfonylurea treatment. Diabetes Care. 2015;38(3):e38-9. doi:10.2337/dc14-2124  PMID:25715421 
  65. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatr Diabetes. 2015. doi:10.1111/pedi.12264  PMID:25690268 
  66. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64(2):631-42. doi:10.2337/db14-0930  PMCID:PMC4303965  PMID:25204977 
  67. Mother-daughter dyadic approach for starting preconception counseling at puberty in girls with diabetes. Res J Womens Health. 2014;1. PMCID:PMC4316737  PMID:25664183 
  68. Persistently high glucose levels in young children with type 1 diabetes. Pediatr Diabetes. 2014. doi:10.1111/pedi.12248  PMCID:PMC4465416  PMID:25496062 
  69. Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome. J AAPOS. 2014;18(5):461-465.e1. PMCID:PMC4476046  PMID:25439303 
  70. Skin and adhesive issues with continuous glucose monitors: a sticky situation. J Diabetes Sci Technol. 2014;8(4):745-51. PMCID:PMC4764227  PMID:24876416 
  71. Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis. Diabetes Care. 2014;37(6):1741-4. doi:10.2337/dc13-2612  PMCID:PMC4030093  PMID:24696460 
  72. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Diabetologia. 2014;57(5):935-9. PMCID:PMC4158711  PMID:24554005 
  73. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med. 2014. doi:10.1111/dme.12437  PMID:24646311 
  74. Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatr Diabetes. 2014;15(2):127-34. doi:10.1111/pedi.12070  PMCID:PMC3858506  PMID:23992543 
  75. Alterations in white matter structure in young children with type 1 diabetes. Diabetes Care. 2014;37(2):332-40. doi:10.2337/dc13-1388  PMCID:PMC3898758  PMID:24319123 
  76. Cognitive functioning in young children with type 1 diabetes. J Int Neuropsychol Soc. 2014;20(2):238-47. doi:10.1017/S1355617713001434  PMID:24512675 
  77. High success rates of sedation-free brain MRI scanning in young children using simple subject preparation protocols with and without a commercial mock scanner--the Diabetes Research in Children Network (DirecNet) experience. Pediatr Radiol. 2014;44(2):181-6. doi:10.1007/s00247-013-2798-7  PMCID:PMC3946760  PMID:24096802 
  78. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes. 2014;63(1):343-53. doi:10.2337/db13-0179  PMCID:PMC3868050  PMID:24170697 
  79. Long-term effects of the booster-enhanced READY-Girls preconception counseling program on intentions and behaviors for family planning in teens with diabetes. Diabetes Care. 2013;36(12):3870-4. doi:10.2337/dc13-0355  PMCID:PMC3836127  PMID:24130343 
  80. Early response to preventive strategies in the Diabetes Prevention Program. J Gen Intern Med. 2013;28(12):1629-36. doi:10.1007/s11606-013-2548-4  PMCID:PMC3832727  PMID:23860722 
  81. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience. Diabetes Care. 2013;36(6):1765-71. doi:10.2337/dc12-2390  PMCID:PMC3661822  PMID:23704676 
  82. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care. 2013;36(6):1749-57. doi:10.2337/dc12-2393  PMCID:PMC3661836  PMID:23704674 
  83. Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2013;36(5):e63. doi:10.2337/dc12-2021  PMCID:PMC3631880  PMID:23613604 
  84. Phenotypic characteristics of early Wolfram syndrome. Orphanet J Rare Dis. 2013;8:64. doi:10.1186/1750-1172-8-64  PMCID:PMC3651298  PMID:23981289 
  85. White matter microstructural integrity in youth with type 1 diabetes. Diabetes. 2013;62(2):581-9. doi:10.2337/db12-0696  PMCID:PMC3554385  PMID:23139349 
  86. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes. Diabetes Care. 2013. doi:10.2337/dc12-1697  PMID:23288858 
  87. The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care. 2012;35(9):1864-7. doi:10.2337/dc11-2301  PMCID:PMC3425006  PMID:22751958 
  88. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012;13(5):376-83. doi:10.1111/j.1399-5448.2011.00841.x  PMCID:PMC3355206  PMID:22332798 
  89. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243-51. PMCID:PMC3555407  PMID:22683134 
  90. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366(24):2247-56. doi:10.1056/NEJMoa1109333  PMCID:PMC3478667  PMID:22540912 
  91. Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes. 2012;13(4):301-7. doi:10.1111/j.1399-5448.2011.00837.x  PMID:22151826 
  92. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care. 2012;35(4):817-20. doi:10.2337/dc11-2190  PMCID:PMC3308298  PMID:22323414 
  93. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care. 2012;35(2):204-10. doi:10.2337/dc11-1746  PMCID:PMC3263860  PMID:22210571 
  94. Prospectively determined impact of type 1 diabetes on brain volume during development. Diabetes. 2011;60(11):3006-14. doi:10.2337/db11-0589  PMCID:PMC3198062  PMID:21953611 
  95. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med. 2011;171(5):412-20. PMCID:PMC3085024  PMID:21403038 
  96. Case of hypercalcemia secondary to hypervitaminosis a in a 6-year-old boy with autism. Case Rep Endocrinol. 2011;2011:424712. doi:10.1155/2011/424712  PMCID:PMC3420388  PMID:22937283 
  97. Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation. Pediatr Diabetes. 2010;11(4):286-8. doi:10.1111/j.1399-5448.2009.00557.x  PMCID:PMC3245710  PMID:19656320 
  98. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-53. doi:10.2337/db09-1216  PMCID:PMC2857905  PMID:20150283 
  99. Camp jump start: effects of a residential summer weight-loss camp for older children and adolescents. Pediatrics. 2010;125(4):e884-90. doi:10.1542/peds.2009-1007  PMID:20194273 
  100. Hippocampal volumes in youth with type 1 diabetes. Diabetes. 2010;59(1):236-41. doi:10.2337/db09-1117  PMCID:PMC2797927  PMID:19833895 
  101. Psychosocial resources and barriers to self-management in African American adolescents with type 2 diabetes: a qualitative analysis. Diabetes Educ. 2010;36(4):613-22. doi:10.1177/0145721710369706  PMID:20479133 
  102. Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care. 2009;32(3):387-93. doi:10.2337/dc08-0800  PMCID:PMC2646014  PMID:19106380 
  103. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol. 2008;126(12):1707-15. doi:10.1001/archopht.126.12.1707  PMCID:PMC2663518  PMID:19064853 
  104. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. J Pediatr. 2008;153(4):547-53. doi:10.1016/j.jpeds.2008.04.063  PMID:18589448 
  105. Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial. J Pediatr Endocrinol Metab. 2008;21(6):555-68. PMID:18717242 
  106. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes. 2008;9(2):87-95. doi:10.1111/j.1399-5448.2007.00274.x  PMID:18208449 
  107. Randomized, controlled trial of Behavioral Family Systems Therapy for Diabetes: maintenance and generalization of effects on parent-adolescent communication. Behav Ther. 2008;39(1):33-46. doi:10.1016/j.beth.2007.04.001  PMID:18328868 
  108. Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care. 2007;30(9):2331-7. doi:10.2337/dc07-0351  PMID:17575089 
  109. Randomized trial of behavioral family systems therapy for diabetes: maintenance of effects on diabetes outcomes in adolescents. Diabetes Care. 2007;30(3):555-60. doi:10.2337/dc06-1613  PMID:17327320 
  110. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology. 2007;242(3):846-56. doi:10.1148/radiol.2423060111  PMID:17244720 
  111. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care. 2007;30(1):38-42. doi:10.2337/dc06-1615  PMID:17192330 
  112. Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control. J Pediatr Psychol. 2006;31(9):928-38. doi:10.1093/jpepsy/jsj098  PMID:16401678 
  113. Knowledge, attitudes and behaviors related to sexuality and family planning in adolescent women with and without diabetes. Pediatr Diabetes. 2006;7(5):267-73. doi:10.1111/j.1399-5448.2006.00197.x  PMID:17054448 
  114. Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2006;29(3):643-9. PMID:16505520 
  115. Self-care autonomy and outcomes of intensive therapy or usual care in youth with type 1 diabetes. J Pediatr Psychol. 2006;31(10):1036-45. doi:10.1093/jpepsy/jsj017  PMID:15772362 
  116. Risk of retinopathy in children with type 1 diabetes mellitus before 2 years of age. Am J Ophthalmol. 2005;140(5):930-1. doi:10.1016/j.ajo.2005.05.023  PMID:16310480 
  117. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care. 2005;28(10):2372-7. PMID:16186265 
  118. A prospective study of severe hypoglycemia and long-term spatial memory in children with type 1 diabetes. Pediatr Diabetes. 2004;5(2):63-71. doi:10.1111/j.1399-543X.2004.00045.x  PMID:15189491 
  119. Management of diabetic ketoacidosis. Rev Endocr Metab Disord. 2003;4(4):343-53. PMID:14618019 
  120. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 2003;88(10):4840-7. doi:10.1210/jc.2003-030855  PMID:14557463 
  121. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care. 2003;26(7):2043-7. PMID:12832310 
  122. Severe hypoglycemia and long-term spatial memory in children with type 1 diabetes mellitus: a retrospective study. J Int Neuropsychol Soc. 2003;9(5):740-50. doi:10.1017/S1355617703950077  PMID:12901780 
  123. Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care. 2003;26(4):1100-5. PMID:12663580 
  124. Condom use, pregnancy, and STDs in adolescent females with and without type 1 diabetes. Diabetes Educ. 2003;29(1):135-43. PMID:12632692 
  125. The effect of severe hypoglycaemia on cognition in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab. 2002;15(6):426-9. PMID:12678462 
  126. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr. 2001;139(6):804-12. PMID:11743505 
  127. Behavior therapy for families of adolescents with diabetes: maintenance of treatment effects. Diabetes Care. 2001;24(3):441-6. PMID:11289465 
  128. Reproductive health beliefs and behaviors in teens with diabetes: application of the Expanded Health Belief Model. Pediatr Diabetes. 2001;2(1):30-9. doi:10.1046/j.1399-543x.2001.00000.x  PMID:15016208 
  129. Comparison of single-mother and two-parent families on metabolic control of children with diabetes. Diabetes Care. 2001;24(2):234-8. PMID:11213871 
  130. Influence of family structure on health among youths with diabetes. Health Soc Work. 2001;26(1):7-14. PMID:11338282 
  131. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr. 2001;138(2):244-9. PMID:11174623 
  132. Diabetic ketoacidosis in children. Endocrinol Metab Clin North Am. 2000;29(4):657-82. PMID:11149156 
  133. Validation of a structured interview for the assessment of diabetes self-management. Diabetes Care. 2000;23(9):1301-4. PMID:10977022 
  134. Defective insulin receptors in Rabson-Mendenhall syndrome cause complete peripheral insulin resistance but minimal hepatic insulin response remains. Pediatr Diabetes. 2000;1(2):66-73. doi:10.1034/j.1399-5448.2000.010203.x  PMID:15016231 
  135. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2000;2(1):49-56. doi:10.1089/152091500316737  PMID:11467320 
  136. Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol. 2000;25(1):23-33. PMID:10826241 
  137. Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care. 1999;22(8):1318-24. PMID:10480777 
  138. Management of the young child with diabetes mellitus: how do we measure success? Mayo Clin Proc. 1999;74(3):309-11. doi:10.4065/74.3.309  PMID:10090001 
  139. Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. J Int Neuropsychol Soc. 1997;3(6):509-20. PMID:9448364 
  140. Social validity of support group and behavior therapy interventions for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol. 1997;22(5):635-49. PMID:9383927 
  141. Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes. Family and community contexts. Diabetes Care. 1997;20(10):1569-75. PMID:9314637 
  142. Comparison of transplanted islets in patients with functioning versus nonfunctioning allografts. Transplant Proc. 1997;29(4):2241-2. PMID:9193609 
  143. Long-term (> 30 months) follow-up of a single successful kidney-islet transplant recipient. Transplant Proc. 1997;29(4):2231-3. PMID:9193605 
  144. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc. 1997;29(4):2268-9. PMID:9193621 
  145. Definitions, causes, and risk factors for hypoglycemia in insulin-dependent diabetes. Curr Ther Endocrinol Metab. 1997;6:447-53. PMID:9174787 
  146. Major decrements in glycated hemoglobin levels between 1978 and 1989 in patients with insulin-dependent diabetes mellitus. J Diabetes Complications. 1996;10(1):12-7. PMID:8639968 
  147. A rapid radioimmunoassay for the measurement of antibodies to glutamic acid decarboxylase in human serum. Horm Metab Res. 1995;27(6):293-5. doi:10.1055/s-2007-979962  PMID:7557842 
  148. Modification of methodology results in improvement in simultaneous kidney-islet success. Transplant Proc. 1995;27(1):1349-50. PMID:7878907 
  149. Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus. Arch Intern Med. 1994;154(22):2597-602. PMID:7979857 
  150. Definitions, causes, and risk factors for hypoglycemia in insulin-dependent diabetes. Curr Ther Endocrinol Metab. 1994;5:406-12. PMID:7704763 
  151. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17(1):37-41. PMID:1986902 
  152. Randomized prospective study of self-management training with newly diagnosed diabetic children. Diabetes Care. 1990;13(5):492-8. PMID:2351027 
  153. Prevalence and consequences of nocturnal hypoglycemia among conventionally treated children with diabetes mellitus. J Pediatr. 1990;116(5):685-9. PMID:2184211 
  154. In-hospital bedside blood glucose monitoring: the importance of a quality control program. J Pediatr Nurs. 1989;4(5):353-6. PMID:2614651 
  155. Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 years. J Infect Dis. 1989;159(6):1013-7. PMID:2542418 
  156. The intensive insulin therapy team. Diabetes Educ. 1989;15(3):249-52. PMID:2653759 
  157. Self-monitoring of blood glucose by adolescents with diabetes: technical skills and utilization of data. Diabetes Educ. 1989;15(1):56-61. PMID:2910690 
  158. Physiologic responses to acute psychological stress in adolescents with type 1 diabetes mellitus. J Pediatr Psychol. 1988;13(1):69-86. PMID:3385578 
  159. Evaluation of a new system for self blood glucose monitoring. Diabetes Res Clin Pract. 1988;4(3):209-13. PMID:3359921 
  160. Dietary skills and adherence in children with type I diabetes mellitus. Diabetes Educ. 1988;14(1):33-6. PMID:3335182 
  161. Failure of nocturnal hypoglycemia to cause fasting hyperglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1987;317(25):1552-9. doi:10.1056/NEJM198712173172502  PMID:3317053 
  162. Stress and coping in relation to metabolic control of adolescents with type 1 diabetes. J Dev Behav Pediatr. 1987;8(3):136-40. PMID:3597781 
  163. The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes. Diabetes Res Clin Pract. 1987;3(1):39-44. PMID:3493126 
  164. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus. Endocr Rev. 1986;7(2):131-9. doi:10.1210/edrv-7-2-131  PMID:2873031 
  165. Glycemic control and bone age are independently associated with muscle capillary basement membrane width in diabetic children after puberty. Diabetes Care. 1986;9(5):453-9. PMID:3769715 
  166. Insulin clearance contributes to the variability of nocturnal insulin requirement in insulin-dependent diabetes mellitus. Diabetes. 1985;34(12):1260-5. PMID:3905459 
  167. Failure of ultracentrifugation as a means of separating plasma free insulin from immunoglobulin fraction prior to radioimmunoassay. Clin Chim Acta. 1985;152(1-2):11-5. PMID:3902294 
  168. Plasma pancreatic polypeptide response to insulin-induced hypoglycemia as a marker for defective glucose counterregulation in insulin-dependent diabetes mellitus. Diabetes. 1985;34(9):870-5. PMID:2993084 
  169. X-linked glycogen storage disease. A cause of hypotonia, hyperuricemia, and growth retardation. Am J Dis Child. 1985;139(6):609-13. PMID:3859203 
  170. Influence of growth hormone on overnight insulin requirements in insulin-dependent diabetes. Diabetes. 1985;34(2):135-9. PMID:2857143 
  171. Myocardial bethanidine kinetics after single-dose intravenous infusion: correlation with plasma kinetics in closed-chest dogs. J Cardiovasc Pharmacol. 1985;7(3):609-12. PMID:2410697 
  172. Defective glucose counterregulation limits intensive therapy of diabetes mellitus. Am J Physiol. 1984;247(2 Pt 1):E215-20. PMID:6380308 
  173. The juvenile human endocrine pancreas: normal v idiopathic hyperinsulinemic hypoglycemia. Semin Diagn Pathol. 1984;1(1):30-42. PMID:6400628 
  174. Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients. Diabetes. 1984;33(1):60-3. PMID:6360768 
  175. Urinary adenosine 3',5'-monophosphate excretion in normal children and children with type I diabetes mellitus. Horm Metab Res. 1984;16(1):50-1. doi:10.1055/s-2007-1014691  PMID:6321312 
  176. Roles of site and timing of the morning insulin injection in type 1 diabetes. J Pediatr. 1983;103(4):528-33. PMID:6352884 
  177. Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics. J Clin Endocrinol Metab. 1983;57(1):94-100. doi:10.1210/jcem-57-1-94  PMID:6853683 
  178. Examination of the role of the pituitary-adrenocortical axis, counterregulatory hormones, and insulin clearance in variable nocturnal insulin requirements in insulin-dependent diabetes. Diabetes. 1983;32(5):403-7. PMID:6341122 
  179. Persistent leucine sensitivity following partial pancreatectomy and diazoxide treatment. Therapeutic response. Am J Dis Child. 1983;137(4):393-5. PMID:6829520 
  180. Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med. 1983;308(9):485-91. doi:10.1056/NEJM198303033080903  PMID:6337335 
  181. Auditory function in children with diabetes mellitus. Ann Otol Rhinol Laryngol. 1983;92(3 Pt 1):237-41. PMID:6344724 
  182. Dawn phenomenon and intensified therapy. Diabetes Care. 1983;6(5):525-6. PMID:6400714 
  183. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982;97(2):210-3. PMID:7103278 
  184. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes. 1982;31(1):80-5. PMID:6759217 
  185. Clinical and histologic indications for extensive pancreatic resection in nesidioblastosis. Am J Surg. 1982;143(1):116-9. PMID:7032331 
  186. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy. Diabetes Care. 1982;5 Suppl 1:6-10. PMID:6231169 
  187. Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J Clin Endocrinol Metab. 1981;53(6):1154-9. doi:10.1210/jcem-53-6-1154  PMID:7028772 
  188. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. J Pediatr. 1981;99(1):41-5. PMID:7019402 
  189. Plasma somatomedins in children with hyperinsulinism. J Clin Endocrinol Metab. 1981;52(4):748-50. doi:10.1210/jcem-52-4-748  PMID:7204541 
  190. Plasma somatomedins, endogenous insulin secretion, and growth in transient neonatal diabetes mellitus. J Clin Endocrinol Metab. 1981;52(1):144-7. doi:10.1210/jcem-52-1-144  PMID:7005255 
  191. Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes. Ann Biomed Eng. 1980;8(4-6):525-38. PMID:6794390 
Last updated: 10/18/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130